Dora Ding

Dora Ding is the Director of Biostatistics at Gilead Sciences, where they have been since 2020. With 20 years of clinical trial experience across the pharmaceutical, biotechnology, and CRO sectors, they have worked on numerous Phase 1 through Phase 4 studies in diverse fields such as neuroscience, oncology, and infectious diseases. Dora holds a medical degree from Peking University Health Science Center, as well as Master's degrees in Biostatistics and Human Genetics from UCLA. Their strong programming skills in SAS enable them to execute and interpret complex clinical trial analyses effectively. Previously, Dora held various positions at Gilead Sciences and other reputable companies like inVentiv Health Clinical and Quintiles.